NEW YORK (GenomeWeb News) – ResearchDx today announced a partnership with CompanDx that it said will result in "a full capability to discover and deliver novel molecular diagnostic tests."
The collaboration draws on ResearchDx's ability to design, produce, and validate tests, and CompanDx's Distiller platform to deliver small composite biomarker signatures from complex data of high dimensionality. As a result, clients will be able to initiate the parallel development of companion diagnostics from the earliest stages of drug development, ResearchDx said.
Financial and other terms of the deal were not disclosed.
Based in Irvine, Calif., ResearchDx is a contract diagnostics organization for the biopharmaceutical and diagnostic industries.
CompanDx is a molecular diagnostics firm based in Nottingham, UK. Earlier this year it and Clinical Reference Laboratory announced a collaboration to develop biomarker panels and companion diagnostics.